AKRO
Price
$42.38
Change
+$1.38 (+3.37%)
Updated
Apr 28, 04:28 PM (EDT)
Capitalization
3.26B
22 days until earnings call
VTYX
Price
$1.23
Change
+$0.03 (+2.50%)
Updated
Apr 28, 11:09 AM (EDT)
Capitalization
85.39M
10 days until earnings call
Ad is loading...

AKRO vs VTYX

Header iconAKRO vs VTYX Comparison
Open Charts AKRO vs VTYXBanner chart's image
Akero Therapeutics
Price$42.38
Change+$1.38 (+3.37%)
Volume$500
Capitalization3.26B
Ventyx Biosciences
Price$1.23
Change+$0.03 (+2.50%)
Volume$100
Capitalization85.39M
AKRO vs VTYX Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. VTYX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a Buy and VTYX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 28, 2025
Stock price -- (AKRO: $41.00 vs. VTYX: $1.20)
Brand notoriety: AKRO and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 91% vs. VTYX: 91%
Market capitalization -- AKRO: $3.26B vs. VTYX: $85.39M
AKRO [@Biotechnology] is valued at $3.26B. VTYX’s [@Biotechnology] market capitalization is $85.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, AKRO is a better buy in the long-term than VTYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • AKRO’s TA Score: 5 bullish, 5 bearish.
  • VTYX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than AKRO.

Price Growth

AKRO (@Biotechnology) experienced а +8.96% price change this week, while VTYX (@Biotechnology) price change was +12.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.03%. For the same industry, the average monthly price growth was +0.98%, and the average quarterly price growth was -8.84%.

Reported Earning Dates

AKRO is expected to report earnings on Aug 08, 2025.

VTYX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($3.26B) has a higher market cap than VTYX($85.4M). AKRO YTD gains are higher at: 47.376 vs. VTYX (-45.205). VTYX has higher annual earnings (EBITDA): -147.1M vs. AKRO (-247.37M). AKRO has more cash in the bank: 743M vs. VTYX (217M). VTYX has less debt than AKRO: VTYX (10.8M) vs AKRO (36.5M). AKRO (0) and VTYX (0) have equivalent revenues.
AKROVTYXAKRO / VTYX
Capitalization3.26B85.4M3,822%
EBITDA-247.37M-147.1M168%
Gain YTD47.376-45.205-105%
P/E RatioN/AN/A-
Revenue00-
Total Cash743M217M342%
Total Debt36.5M10.8M338%
FUNDAMENTALS RATINGS
AKRO: Fundamental Ratings
AKRO
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKROVTYX
RSI
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 7 days ago
85%
MACD
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 21 days ago
84%
Bearish Trend 22 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
83%
Aroon
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
85%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+0.02%
ETNB - AKRO
60%
Loosely correlated
+0.58%
SLS - AKRO
41%
Loosely correlated
+4.48%
TRDA - AKRO
38%
Loosely correlated
-1.34%
VTYX - AKRO
38%
Loosely correlated
-4.76%
MDGL - AKRO
37%
Loosely correlated
+2.14%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
-4.76%
KYMR - VTYX
41%
Loosely correlated
-0.89%
IMNM - VTYX
40%
Loosely correlated
-1.41%
FDMT - VTYX
40%
Loosely correlated
+2.77%
BHVN - VTYX
40%
Loosely correlated
-15.21%
ABUS - VTYX
39%
Loosely correlated
-1.50%
More